Professor Lencioni ILCA 2011.pdf - Biocompatibles

ePAPER READ

DOWNLOAD ePAPER

assets.biocompatibles.com

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

SongMalagariPoonVarela<strong>Lencioni</strong>ReyesLLovetLoDEBDOX vs conventional Lipiodol TACE:Tumor response ratesTumor Response Rate (%)8580 -70 -60 -50 -737066606052444030--352720-10-0DEBDOXPRECISION VcTACE<strong>Lencioni</strong> R. Personal communication.

Drug-Eluting Bead TACE with DC BeadÂ® [DEBDOXâ¢] in the ...

Bead Block embosphere EC10-141 A4 ROW web.pdf - Biocompatibles

IVMPRC12-018 New Bead Block Brochure.pdf - Biocompatibles

DC Bead: In Vitro Characterization of a Drug ... - Biocompatibles

Drug-Eluting Beads Versus Conventional TACE - Biocompatibles

EC12-075(T) Rev 1 Dox M1 brochure.pdf - Biocompatibles

PRECISION V Trial Overview and Initial Data Presentation - Onsite TV

DEBIRI Detail Aid CE Approved spreads.pdf - Biocompatibles

Drug-eluting beads: a pharmaceutical assessment - Biocompatibles

DEBDOX vs cTACE: Response rates are higherin patients with more advanced diseaseDEBDOX shows significant advantagefor objective response (p=0.038)and disease control (p=0.026)Lammer J et al. Cardiovasc Intervent Radiol 2010;33:41-52

Page 1 and 2: Is DEBDOX the New Standardfor Chemo
Page 3 and 4: BCLC staging system and treatment s
Page 5 and 6: Probability of survival (%)Probabil
Page 7 and 8: Conventional TACE: treatment discon
Page 9 and 10: Drug eluting bead doxorubicin (DEBD
Page 11: DEBDOX vs cTACE: Response rates are
Page 15: DEBDOX vs conventional Lipiodol TAC

Professor Lencioni ILCA 2011.pdf - Biocompatibles

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?